Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1 beta and tumor necrosis factor.
Inflamm. Res., Jan;54(1):10-6 (2005)
A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition.
J. Biol. Chem., Aug;276(35):33156-64 (2001)
Crystallization and preliminary X-ray diffraction studies of a new crystal form of human secretory type IIA phospholipase A2.
Acta Crystallogr. D Biol. Crystallogr., Nov;56(Pt 11):1482-4 (2000)
Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.
J. Immunol., Sep;165(5):2790-7 (2000)
Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflammation.
J. Leukoc. Biol., Oct;66(4):535-41 (1999)
Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.
Ann. Rheum. Dis., Sep;57(9):550-8 (1998)
Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
J. Endocrinol., Apr;153(1):151-7 (1997)
Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence.
J. Biol. Chem., Sep;271(39):23992-8 (1996)
Localization of type II phospholipase A2 messenger RNA and immunoactivity in human placenta and fetal membranes.
Placenta., Sep;17(7):423-9 (1996)
Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
Biochim. Biophys. Acta., Nov;1170(3):314-20 (1993)
Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity.
Biochim. Biophys. Acta., Feb;1166(1):77-83 (1993)